Ara Dikranian(@RumorDoc) 's Twitter Profileg
Ara Dikranian

@RumorDoc

Passionate about rheumatology, travel, human nature, gastronomy

ID:881970102152736769

calendar_today03-07-2017 20:17:13

481 Tweets

455 Followers

132 Following

Confideo(@ConfideoLabs) 's Twitter Profile Photo

As technology advances, media applications continue to transform education and engagement. Healthcare stakeholders can access a myriad of multi-dimensional learning opportunities that improve the retention of complex information. 

As visual learners, healthcare professionals are

As technology advances, media applications continue to transform education and engagement. Healthcare stakeholders can access a myriad of multi-dimensional learning opportunities that improve the retention of complex information.  As visual learners, healthcare professionals are
account_circle
Ara Dikranian(@RumorDoc) 's Twitter Profile Photo

Dr Philipp Sewerin presents findings from German ArthroMark cohort where baseline MRI RAMRIS score predicted EULAR response in RA doi.org/10.3899/jrheum… Philipp Sewerin, MD, PhD Association of Women in Rheumatology

Dr Philipp Sewerin presents findings from German ArthroMark cohort where baseline MRI RAMRIS score predicted EULAR response in RA doi.org/10.3899/jrheum… @philippsewerin @AWIRGROUP
account_circle
Ara Dikranian(@RumorDoc) 's Twitter Profile Photo

First human MRI 1977 using 0.05T progressed to clarity in modern images within 1-2 generations presented by Dr Philipp Sewerin at AWIR San Diego summit. Philipp Sewerin, MD, PhD Association of Women in Rheumatology

First human MRI 1977 using 0.05T progressed to clarity in modern images within 1-2 generations presented by Dr Philipp Sewerin at AWIR San Diego summit. @philippsewerin @AWIRGROUP
account_circle
Ara Dikranian(@RumorDoc) 's Twitter Profile Photo

“Physician global impression on RA control changes DMARD prescription, while patient global changes DMARD adherence” —Dr. Michaud

account_circle
Ara Dikranian(@RumorDoc) 's Twitter Profile Photo

Sad to see Olumiant's attempt to be an effective therapy for lupus come to an end based on weak efficacy data, no new safety signals. Potential indication for atopic dermatitis also appears doubtful. prn.to/35yl2Bl

account_circle
Ara Dikranian(@RumorDoc) 's Twitter Profile Photo

Congratulations to patients with ankylosing spondylitis who now have another therapeutic option with . Proud to partner with Pfizer Inc. in helping manage this disease!

account_circle
Ara Dikranian(@RumorDoc) 's Twitter Profile Photo

FDA Approves Cyltezo, the First Interchangeable Biosimilar to Humira and only second interchangeable Biosimilar overall in US, coming 2023 fda.gov/news-events/pr…

account_circle